CAS: 1884201-71-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Mirikizumab REF: TM-T77088CAS: 1884201-71-1 | 95% - 95% | 219.00 €~1,745.00 € | Mon 21 Apr 25 |
 | Mirikizumab REF: 3D-CLA1496CAS: 1884201-71-1 | - - - | To inquire | Fri 02 May 25 |
Mirikizumab
CAS:1884201-71-1
Mirikizumab (LY3074828) is a humanized antibody targeting the p19 subunit of interleukin-23 (IL-23).
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T77088
| 1mg | 219.00 € | ||
| 5mg | 568.00 € | ||
| 10mg | 904.00 € | ||
| 25mg | 1,337.00 € | ||
| 50mg | 1,745.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Mirikizumab
CAS:1884201-71-1
A humanized IgG4 monoclonal antibody targeting p19 subunit of interleukin 23.
Ref: 3D-CLA1496
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 2 May 2025
